Myasthenia gravis (MG) is an autoimmune disease characterized by production
of antibodies to acetylcholine receptor at the motor end-plate responsible
for impairment of neuromuscular transmission. There is general agreement a
bout the involvement of the thymus in the pathogenesis of MG, and thymic pa
thological changes are commonly found in MG patients. Genetic factors seem
to play an important role in susceptibility to MG. As with other autoimmune
diseases, genetic predisposition to MG probably involves multiple genes. A
mple evidence suggests that genes within the major histocompatibility compl
ex (MHC) are involved in susceptibility to autoimmune diseases. Both data f
rom the literature and our findings indicate that different genes within th
e MHC could predispose to various forms of MG, and that particularly the tu
mour necrosis factor genes may play a role in the association between the d
ifferent thymic disorders and MG.